SCHEMBL13044992

SCHEMBL13044992

CSCC[C@H](N)C(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13044988 1.00
SCHEMBL15241782 0.82
SCHEMBL13208861 0.78
SCHEMBL14599212 0.78
SCHEMBL23707005 0.76
SCHEMBL9160497 0.76
SCHEMBL13044994 0.75 METAP2 (0.40)
SCHEMBL5848331 0.75 METAP2 (0.50)
SCHEMBL11533489 0.74
SCHEMBL17785087 0.72 RNPEP (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210403571-A1 SYNERGISTIC COMBINATIONS OF METHIONINE DEPLETION AGENTS AND IMMUNE CHECKPOINT MODULATORS ERYTECH PHARMA (FR) 2021-12-30 US disclosed
EP-3146977-A1 TFPI INHIBITORS AND METHODS OF USE Baxalta GmbH (CH) 2017-03-29 EP disclosed
US-20100292224-A1 ISOTHIAZOLIDINE 1,1-DIOXIDE AND TETRAHYDRO-2H-1,2-THIAZINE 1,1-DIOXIDE DERIVATIVES AS P2X7 MODULATORS GLAXO GROUP LIMITED (GB) 2010-11-18 US disclosed